Global and USA Human Vaccine Adjuvants Market Insights, Forecast to 2027

Human Vaccine Adjuvants market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Human Vaccine Adjuvants market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2016-2027.

For USA market, this report focuses on the Human Vaccine Adjuvants market size by players, by Type, and by Application, for the period 2016-2027. The key players include the global and local players which play important roles in USA.

Oral

Subcutaneous

Intramuscular

Others

Research Applications

Commercial Applications

North America

the United States

Canada

Europe

Germany

France

UK

Italy

Russia

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Indonesia

Thailand

Malaysia

Latin America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

GSK

CSL Limited

Brenntag Biosector

SEPPIC

SPI Pharma

Novavax

Avanti Polar Lipids

Aphios

1.1 Human Vaccine Adjuvants Product Introduction

1.2 Market by Type

1.2.1 Global Human Vaccine Adjuvants Market Size Growth Rate by Type

1.2.2 Oral

1.2.3 Subcutaneous

1.2.4 Intramuscular

1.2.5 Others

1.3 Market by Application

1.3.1 Global Human Vaccine Adjuvants Market Size Growth Rate by Application

1.3.2 Research Applications

1.3.3 Commercial Applications

1.4 Study Objectives

1.5 Years Considered

2.1 Global Human Vaccine Adjuvants Market Size, Estimates and Forecasts

2.1.1 Global Human Vaccine Adjuvants Revenue 2016-2027

2.1.2 Global Human Vaccine Adjuvants Sales 2016-2027

2.2 Global Human Vaccine Adjuvants, Market Size by Region: 2016 VS 2021 VS 2027

2.3 Human Vaccine Adjuvants Historical Market Size by Region (2016-2021)

2.3.1 Global Human Vaccine Adjuvants Retrospective Market Scenario in Sales by Region: 2016-2021

2.3.2 Global Human Vaccine Adjuvants Retrospective Market Scenario in Revenue by Region: 2016-2021

2.4 Human Vaccine Adjuvants Market Estimates and Projections by Region (2022-2027)

2.4.1 Global Human Vaccine Adjuvants Sales Forecast by Region (2022-2027)

2.4.2 Global Human Vaccine Adjuvants Revenue Forecast by Region (2022-2027)

3.1 Global Top Human Vaccine Adjuvants Manufacturers by Sales

3.1.1 Global Human Vaccine Adjuvants Sales by Manufacturer (2016-2021)

3.1.2 Global Human Vaccine Adjuvants Sales Market Share by Manufacturer (2016-2021)

3.2 Global Top Human Vaccine Adjuvants Manufacturers by Revenue

3.2.1 Key Human Vaccine Adjuvants Manufacturers Covered: Ranking by Revenue

3.2.2 Global Human Vaccine Adjuvants Revenue by Manufacturers (2016-2021)

3.2.3 Global Human Vaccine Adjuvants Revenue Share by Manufacturers (2016-2021)

3.2.4 Global Human Vaccine Adjuvants Market Concentration Ratio (CR5 and HHI) (2016-2021)

3.2.5 Global Top 10 and Top 5 Companies by Human Vaccine Adjuvants Revenue in 2020

3.2.6 Global Human Vaccine Adjuvants Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

3.3 Global Human Vaccine Adjuvants Price by Manufacturers

3.4 Global Human Vaccine Adjuvants Manufacturing Base Distribution, Product Types

3.4.1 Human Vaccine Adjuvants Manufacturers Manufacturing Base Distribution, Headquarters

3.4.2 Manufacturers Human Vaccine Adjuvants Product Type

3.4.3 Date of International Manufacturers Enter into Human Vaccine Adjuvants Market

3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4.1 Global Human Vaccine Adjuvants Market Size by Type (2016-2021)

4.1.1 Global Human Vaccine Adjuvants Sales by Type (2016-2021)

4.1.2 Global Human Vaccine Adjuvants Revenue by Type (2016-2021)

4.1.3 Human Vaccine Adjuvants Average Selling Price (ASP) by Type (2016-2021)

4.2 Global Human Vaccine Adjuvants Market Size Forecast by Type (2022-2027)

4.2.1 Global Human Vaccine Adjuvants Sales Forecast by Type (2022-2027)

4.2.2 Global Human Vaccine Adjuvants Revenue Forecast by Type (2022-2027)

4.2.3 Human Vaccine Adjuvants Average Selling Price (ASP) Forecast by Type (2022-2027)

5.1 Global Human Vaccine Adjuvants Market Size by Application (2016-2021)

5.1.1 Global Human Vaccine Adjuvants Sales by Application (2016-2021)

5.1.2 Global Human Vaccine Adjuvants Revenue by Application (2016-2021)

5.1.3 Human Vaccine Adjuvants Price by Application (2016-2021)

5.2 Human Vaccine Adjuvants Market Size Forecast by Application (2022-2027)

5.2.1 Global Human Vaccine Adjuvants Sales Forecast by Application (2022-2027)

5.2.2 Global Human Vaccine Adjuvants Revenue Forecast by Application (2022-2027)

5.2.3 Global Human Vaccine Adjuvants Price Forecast by Application (2022-2027)

6.1 USA Human Vaccine Adjuvants Market Size YoY Growth 2016-2027

6.1.1 USA Human Vaccine Adjuvants Sales YoY Growth 2016-2027

6.1.2 USA Human Vaccine Adjuvants Revenue YoY Growth 2016-2027

6.1.3 USA Human Vaccine Adjuvants Market Share in Global Market 2016-2027

6.2 USA Human Vaccine Adjuvants Market Size by Players (International and Local Players)

6.2.1 USA Top Human Vaccine Adjuvants Players by Sales (2016-2021)

6.2.2 USA Top Human Vaccine Adjuvants Players by Revenue (2016-2021)

6.3 USA Human Vaccine Adjuvants Historic Market Review by Type (2016-2021)

6.3.1 USA Human Vaccine Adjuvants Sales Market Share by Type (2016-2021)

6.3.2 USA Human Vaccine Adjuvants Revenue Market Share by Type (2016-2021)

6.3.3 USA Human Vaccine Adjuvants Price by Type (2016-2021)

6.4 USA Human Vaccine Adjuvants Market Estimates and Forecasts by Type (2022-2027)

6.4.1 USA Human Vaccine Adjuvants Sales Forecast by Type (2022-2027)

6.4.2 USA Human Vaccine Adjuvants Revenue Forecast by Type (2022-2027)

6.4.3 USA Human Vaccine Adjuvants Price Forecast by Type (2022-2027)

6.5 USA Human Vaccine Adjuvants Historic Market Review by Application (2016-2021)

6.5.1 USA Human Vaccine Adjuvants Sales Market Share by Application (2016-2021)

6.5.2 USA Human Vaccine Adjuvants Revenue Market Share by Application (2016-2021)

6.5.3 USA Human Vaccine Adjuvants Price by Application (2016-2021)

6.6 USA Human Vaccine Adjuvants Market Estimates and Forecasts by Application (2022-2027)

6.6.1 USA Human Vaccine Adjuvants Sales Forecast by Application (2022-2027)

6.6.2 USA Human Vaccine Adjuvants Revenue Forecast by Application (2022-2027)

6.6.3 USA Human Vaccine Adjuvants Price Forecast by Application (2022-2027)

7.1 North America Human Vaccine Adjuvants Market Size YoY Growth 2016-2027

7.2 North America Human Vaccine Adjuvants Market Facts & Figures by Country

7.2.1 North America Human Vaccine Adjuvants Sales by Country (2016-2021)

7.2.2 North America Human Vaccine Adjuvants Revenue by Country (2016-2021)

7.2.3 the United States

7.2.4 Canada

8.1 Asia Pacific Human Vaccine Adjuvants Market Size YoY Growth 2016-2027

8.2 Asia Pacific Human Vaccine Adjuvants Market Facts & Figures by Region

8.2.1 Asia Pacific Human Vaccine Adjuvants Sales by Region (2016-2021)

8.2.2 Asia Pacific Human Vaccine Adjuvants Revenue by Region (2016-2021)

8.2.3 China

8.2.4 Japan

8.2.5 South Korea

8.2.6 India

8.2.7 Australia

8.2.8 Australia

8.2.9 Indonesia

8.2.10 Thailand

8.2.11 Malaysia

9.1 Europe Human Vaccine Adjuvants Market Size YoY Growth 2016-2027

9.2 Europe Human Vaccine Adjuvants Market Facts & Figures by Country

9.2.1 Europe Human Vaccine Adjuvants Sales by Country (2016-2021)

9.2.2 Europe Human Vaccine Adjuvants Revenue by Country (2016-2021)

9.2.3 Germany

9.2.4 France

9.2.5 UK

9.2.6 Italy

10.1 Latin America Human Vaccine Adjuvants Market Size YoY Growth 2016-2027

10.2 Latin America Human Vaccine Adjuvants Market Facts & Figures by Country

10.2.1 Latin America Human Vaccine Adjuvants Sales by Country (2016-2021)

10.2.2 Latin America Human Vaccine Adjuvants Revenue by Country (2016-2021)

10.2.3 Mexico

10.2.4 Brazil

10.2.5 Argentina

11.1 Middle East and Africa Human Vaccine Adjuvants Market Size YoY Growth 2016-2027

11.2 Middle East and Africa Human Vaccine Adjuvants Market Facts & Figures by Country

11.2.1 Middle East and Africa Human Vaccine Adjuvants Sales by Country (2016-2021)

11.2.2 Middle East and Africa Human Vaccine Adjuvants Revenue by Country (2016-2021)

11.2.3 Turkey

11.2.4 Saudi Arabia

11.2.5 UAE

12.1 GSK

12.1.1 GSK Corporation Information

12.1.2 GSK Description and Business Overview

12.1.3 GSK Human Vaccine Adjuvants Sales, Revenue and Gross Margin (2016-2021)

12.1.4 GSK Human Vaccine Adjuvants Products Offered

12.1.5 GSK Recent Development

12.2 CSL Limited

12.2.1 CSL Limited Corporation Information

12.2.2 CSL Limited Description and Business Overview

12.2.3 CSL Limited Human Vaccine Adjuvants Sales, Revenue and Gross Margin (2016-2021)

12.2.4 CSL Limited Human Vaccine Adjuvants Products Offered

12.2.5 CSL Limited Recent Development

12.3 Brenntag Biosector

12.3.1 Brenntag Biosector Corporation Information

12.3.2 Brenntag Biosector Description and Business Overview

12.3.3 Brenntag Biosector Human Vaccine Adjuvants Sales, Revenue and Gross Margin (2016-2021)

12.3.4 Brenntag Biosector Human Vaccine Adjuvants Products Offered

12.3.5 Brenntag Biosector Recent Development

12.4 SEPPIC

12.4.1 SEPPIC Corporation Information

12.4.2 SEPPIC Description and Business Overview

12.4.3 SEPPIC Human Vaccine Adjuvants Sales, Revenue and Gross Margin (2016-2021)

12.4.4 SEPPIC Human Vaccine Adjuvants Products Offered

12.4.5 SEPPIC Recent Development

12.5 SPI Pharma

12.5.1 SPI Pharma Corporation Information

12.5.2 SPI Pharma Description and Business Overview

12.5.3 SPI Pharma Human Vaccine Adjuvants Sales, Revenue and Gross Margin (2016-2021)

12.5.4 SPI Pharma Human Vaccine Adjuvants Products Offered

12.5.5 SPI Pharma Recent Development

12.6 Novavax

12.6.1 Novavax Corporation Information

12.6.2 Novavax Description and Business Overview

12.6.3 Novavax Human Vaccine Adjuvants Sales, Revenue and Gross Margin (2016-2021)

12.6.4 Novavax Human Vaccine Adjuvants Products Offered

12.6.5 Novavax Recent Development

12.7 Avanti Polar Lipids

12.7.1 Avanti Polar Lipids Corporation Information

12.7.2 Avanti Polar Lipids Description and Business Overview

12.7.3 Avanti Polar Lipids Human Vaccine Adjuvants Sales, Revenue and Gross Margin (2016-2021)

12.7.4 Avanti Polar Lipids Human Vaccine Adjuvants Products Offered

12.7.5 Avanti Polar Lipids Recent Development

12.8 Aphios

12.8.1 Aphios Corporation Information

12.8.2 Aphios Description and Business Overview

12.8.3 Aphios Human Vaccine Adjuvants Sales, Revenue and Gross Margin (2016-2021)

12.8.4 Aphios Human Vaccine Adjuvants Products Offered

12.8.5 Aphios Recent Development

12.11 GSK

12.11.1 GSK Corporation Information

12.11.2 GSK Description and Business Overview

12.11.3 GSK Human Vaccine Adjuvants Sales, Revenue and Gross Margin (2016-2021)

12.11.4 GSK Human Vaccine Adjuvants Products Offered

12.11.5 GSK Recent Development

13.1 Human Vaccine Adjuvants Industry Trends

13.2 Human Vaccine Adjuvants Market Drivers

13.3 Human Vaccine Adjuvants Market Challenges

13.4 Human Vaccine Adjuvants Market Restraints

14.1 Value Chain Analysis

14.2 Human Vaccine Adjuvants Customers

14.3 Sales Channels Analysis

14.3.1 Sales Channels

14.3.2 Distributors

16.1 Research Methodology

16.1.1 Methodology/Research Approach

16.1.2 Data Source

16.2 Author Details

16.3 Disclaimer

List of Tables

    Table 1. Global Human Vaccine Adjuvants Market Size Growth Rate by Type, 2016 VS 2021 VS 2027 (US$ Million)

    Table 2. Major Manufacturers of Oral

    Table 3. Major Manufacturers of Subcutaneous

    Table 4. Major Manufacturers of Intramuscular

    Table 5. Major Manufacturers of Others

    Table 6. Global Human Vaccine Adjuvants Market Size Growth Rate by Application (2021-2027) & (MT)

    Table 7. Global Human Vaccine Adjuvants Market Size by Region (MT) & (US$ Million), 2016 VS 2021 VS 2027

    Table 8. Global Human Vaccine Adjuvants Sales by Regions (2016-2021) & (MT)

    Table 9. Global Human Vaccine Adjuvants Sales Market Share by Regions (2016-2021)

    Table 10. Global Human Vaccine Adjuvants Revenue by Regions (2016-2021) & (US$ Million)

    Table 11. Global Human Vaccine Adjuvants Sales Forecast by Region (2022-2027) & (MT)

    Table 12. Global Human Vaccine Adjuvants Sales Market Share Forecast by Region (2022-2027)

    Table 13. Global Human Vaccine Adjuvants Revenue Forecast by Region (2022-2027) & (US$ Million)

    Table 14. Global Human Vaccine Adjuvants Revenue Market Share Forecast by Region (2022-2027)

    Table 15. Global Human Vaccine Adjuvants Sales by Manufacturers (2016-2021) (MT)

    Table 16. Global Human Vaccine Adjuvants Sales Share by Manufacturers (2016-2021)

    Table 17. Ranking of Global Top Human Vaccine Adjuvants Manufacturers by Revenue (US$ Million) in 2020

    Table 18. Human Vaccine Adjuvants Revenue by Manufacturers (2016-2021) (US$ Million)

    Table 19. Human Vaccine Adjuvants Revenue Share by Manufacturers (2016-2021)

    Table 20. Global Human Vaccine Adjuvants Manufacturers Market Concentration Ratio (CR5 and HHI) & (2016-2021)

    Table 21. Global Human Vaccine Adjuvants by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Human Vaccine Adjuvants as of 2020)

    Table 22. Key Manufacturers Human Vaccine Adjuvants Price (2016-2021) (USD/Kg)

    Table 23. Human Vaccine Adjuvants Manufacturers Manufacturing Base Distribution and Headquarters

    Table 24. Manufacturers Human Vaccine Adjuvants Product Type

    Table 25. Date of International Manufacturers Enter into Human Vaccine Adjuvants Market

    Table 26. Manufacturers Mergers & Acquisitions, Expansion Plans

    Table 27. Global Human Vaccine Adjuvants Sales by Type (2016-2021) (MT)

    Table 28. Global Human Vaccine Adjuvants Sales Share by Type (2016-2021)

    Table 29. Global Human Vaccine Adjuvants Revenue by Type (2016-2021) (US$ Million)

    Table 30. Global Human Vaccine Adjuvants Revenue Share by Type (2016-2021)

    Table 31. Human Vaccine Adjuvants Average Selling Price (ASP) by Type (2016-2021) & (USD/Kg)

    Table 32. Global Human Vaccine Adjuvants Sales Forecast by Type (2022-2027) & (MT)

    Table 33. Global Human Vaccine Adjuvants Sales Market Share Forecast by Type (2022-2027)

    Table 34. Global Human Vaccine Adjuvants Revenue Forecast V (2022-2027) & (US$ Million)

    Table 35. Global Human Vaccine Adjuvants Revenue Market Share Forecast by Type (2022-2027)

    Table 36. Global Human Vaccine Adjuvants Average Selling Price (ASP) Forecast by Type (2022-2027) & (USD/Kg)

    Table 37. Global Human Vaccine Adjuvants Sales by Application (2016-2021) (MT)

    Table 38. Global Human Vaccine Adjuvants Sales Share by Application (2016-2021)

    Table 39. Global Human Vaccine Adjuvants Revenue by Application (2016-2021) (US$ Million)

    Table 40. Global Human Vaccine Adjuvants Revenue Share by Application (2016-2021)

    Table 41. Human Vaccine Adjuvants Average Selling Price (ASP) by Application (2016-2021) & (USD/Kg)

    Table 42. Global Human Vaccine Adjuvants Sales Forecast by Application (2022-2027) & (MT)

    Table 43. Global Human Vaccine Adjuvants Sales Market Share Forecast by Application (2022-2027)

    Table 44. Global Human Vaccine Adjuvants Revenue Forecast by Application (2022-2027) & (US$ Million)

    Table 45. Global Human Vaccine Adjuvants Revenue Market Share Forecast by Application (2022-2027)

    Table 46. Global Human Vaccine Adjuvants Average Selling Price (ASP) Forecast by Application (2022-2027) & (USD/Kg)

    Table 47. USA Human Vaccine Adjuvants Sales (MT) of Key Companies (2016-2021)

    Table 48. USA Human Vaccine Adjuvants Sales Share by Company (2016-2021)

    Table 49. USA Human Vaccine Adjuvants Revenue (US$ Million) by Company (2016-2021)

    Table 50. USA Human Vaccine Adjuvants Revenue Share by Company (2016-2021)

    Table 51. USA Human Vaccine Adjuvants Sales (MT) by Type (2016-2021)

    Table 52. USA Human Vaccine Adjuvants Sales Share by Type (2016-2021)

    Table 53. USA Human Vaccine Adjuvants Revenue (US$ Million) Market Share by Type (2016-2021)

    Table 54. USA Human Vaccine Adjuvants Price (USD/Kg) by Type (2016-2021)

    Table 55. USA Human Vaccine Adjuvants Sales (MT) by Type (2022-2027)

    Table 56. USA Human Vaccine Adjuvants Sales Share by Type (2022-2027)

    Table 57. USA Human Vaccine Adjuvants Revenue (US$ Million) Market Share by Type (2022-2027)

    Table 58. USA Human Vaccine Adjuvants Revenue Share by Type (2022-2027)

    Table 59. USA Human Vaccine Adjuvants Price (USD/Kg) by Type (2022-2027)

    Table 60. USA Human Vaccine Adjuvants Sales (MT) by Application (2016-2021)

    Table 61. USA Human Vaccine Adjuvants Sales Share by Application (2016-2021)

    Table 62. USA Human Vaccine Adjuvants Revenue (US$ Million) Market Share by Application (2016-2021)

    Table 63. USA Human Vaccine Adjuvants Price (USD/Kg) by Application (2016-2021)

    Table 64. USA Human Vaccine Adjuvants Sales (MT) by Application (2022-2027)

    Table 65. USA Human Vaccine Adjuvants Sales Share by Application (2022-2027)

    Table 66. USA Human Vaccine Adjuvants Revenue (US$ Million) Market Share by Application (2022-2027)

    Table 67. USA Human Vaccine Adjuvants Revenue Share by Application (2022-2027)

    Table 68. USA Human Vaccine Adjuvants Price (USD/Kg) by Application (2022-2027)

    Table 69. North America Human Vaccine Adjuvants Sales by Country (2016-2021) & (MT)

    Table 70. North America Human Vaccine Adjuvants Sales Market Share by Country (2016-2021)

    Table 71. North America Human Vaccine Adjuvants Revenue by Country (2016-2021) & (US$ Million)

    Table 72. North America Human Vaccine Adjuvants Revenue Market Share by Country (2016-2021)

    Table 73. Asia Pacific Human Vaccine Adjuvants Sales by Region (2016-2021) & (MT)

    Table 74. Asia Pacific Human Vaccine Adjuvants Sales Market Share by Region (2016-2021)

    Table 75. Asia Pacific Human Vaccine Adjuvants Revenue by Region (2016-2021) & (US$ Million)

    Table 76. Asia Pacific Human Vaccine Adjuvants Revenue Market Share by Region (2016-2021)

    Table 77. Europe Human Vaccine Adjuvants Sales by Country (2016-2021) & (MT)

    Table 78. Europe Human Vaccine Adjuvants Sales Market Share by Country (2016-2021)

    Table 79. Europe Human Vaccine Adjuvants Revenue by Country (2016-2021) & (US$ Million)

    Table 80. Europe Human Vaccine Adjuvants Revenue Market Share by Country (2016-2021)

    Table 81. Latin America Human Vaccine Adjuvants Sales by Country (2016-2021) & (MT)

    Table 82. Latin America Human Vaccine Adjuvants Sales Market Share by Country (2016-2021)

    Table 83. Latin Americaa Human Vaccine Adjuvants Revenue by Country (2016-2021) & (US$ Million)

    Table 84. Latin America Human Vaccine Adjuvants Revenue Market Share by Country (2016-2021)

    Table 85. Middle East and Africa Human Vaccine Adjuvants Sales by Country (2016-2021) & (MT)

    Table 86. Middle East and Africa Human Vaccine Adjuvants Sales Market Share by Country (2016-2021)

    Table 87. Middle East and Africa Human Vaccine Adjuvants Revenue by Country (2016-2021) & (US$ Million)

    Table 88. Middle East and Africa Human Vaccine Adjuvants Revenue Market Share by Country (2016-2021)

    Table 89. GSK Corporation Information

    Table 90. GSK Description and Business Overview

    Table 91. GSK Human Vaccine Adjuvants Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2016-2021)

    Table 92. GSK Human Vaccine Adjuvants Product

    Table 93. GSK Recent Development

    Table 94. CSL Limited Corporation Information

    Table 95. CSL Limited Description and Business Overview

    Table 96. CSL Limited Human Vaccine Adjuvants Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2016-2021)

    Table 97. CSL Limited Product

    Table 98. CSL Limited Recent Development

    Table 99. Brenntag Biosector Corporation Information

    Table 100. Brenntag Biosector Description and Business Overview

    Table 101. Brenntag Biosector Human Vaccine Adjuvants Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2016-2021)

    Table 102. Brenntag Biosector Product

    Table 103. Brenntag Biosector Recent Development

    Table 104. SEPPIC Corporation Information

    Table 105. SEPPIC Description and Business Overview

    Table 106. SEPPIC Human Vaccine Adjuvants Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2016-2021)

    Table 107. SEPPIC Product

    Table 108. SEPPIC Recent Development

    Table 109. SPI Pharma Corporation Information

    Table 110. SPI Pharma Description and Business Overview

    Table 111. SPI Pharma Human Vaccine Adjuvants Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2016-2021)

    Table 112. SPI Pharma Product

    Table 113. SPI Pharma Recent Development

    Table 114. Novavax Corporation Information

    Table 115. Novavax Description and Business Overview

    Table 116. Novavax Human Vaccine Adjuvants Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2016-2021)

    Table 117. Novavax Product

    Table 118. Novavax Recent Development

    Table 119. Avanti Polar Lipids Corporation Information

    Table 120. Avanti Polar Lipids Description and Business Overview

    Table 121. Avanti Polar Lipids Human Vaccine Adjuvants Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2016-2021)

    Table 122. Avanti Polar Lipids Product

    Table 123. Avanti Polar Lipids Recent Development

    Table 124. Aphios Corporation Information

    Table 125. Aphios Description and Business Overview

    Table 126. Aphios Human Vaccine Adjuvants Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2016-2021)

    Table 127. Aphios Product

    Table 128. Aphios Recent Development

    Table 129. Human Vaccine Adjuvants Market Trends

    Table 130. Human Vaccine Adjuvants Market Drivers

    Table 131. Human Vaccine Adjuvants Market Challenges

    Table 132. Human Vaccine Adjuvants Market Restraints

    Table 133. Human Vaccine Adjuvants Customers List

    Table 134. Human Vaccine Adjuvants Distributors List

    Table 135. Research Programs/Design for This Report

    Table 136. Key Data Information from Secondary Sources

    Table 137. Key Data Information from Primary Sources

List of Figures

    Figure 1. Human Vaccine Adjuvants Product Picture

    Figure 2. Global Human Vaccine Adjuvants Sales Market Share by Type in 2020 & 2027

    Figure 3. Oral Product Picture

    Figure 4. Subcutaneous Product Picture

    Figure 5. Intramuscular Product Picture

    Figure 6. Others Product Picture

    Figure 7. Global Human Vaccine Adjuvants Sales Market Share by Application in 2020 & 2027

    Figure 8. Research Applications

    Figure 9. Commercial Applications

    Figure 10. Human Vaccine Adjuvants Report Years Considered

    Figure 11. Global Human Vaccine Adjuvants Market Size, (US$ Million), 2016 VS 2021 VS 2027

    Figure 12. Global Human Vaccine Adjuvants Market Size 2016-2027 (US$ Million)

    Figure 13. Global Human Vaccine Adjuvants Sales 2016-2027 (MT)

    Figure 14. Global Human Vaccine Adjuvants Market Size Market Share by Region: 2021 Versus 2027

    Figure 15. Global Human Vaccine Adjuvants Sales Market Share by Region (2016-2021)

    Figure 16. Global Human Vaccine Adjuvants Sales Market Share by Region in 2020

    Figure 17. Global Human Vaccine Adjuvants Revenue Market Share by Region (2016-2021)

    Figure 18. Global Human Vaccine Adjuvants Revenue Market Share by Region in 2020

    Figure 19. Global Human Vaccine Adjuvants Sales Share by Manufacturer in 2020

    Figure 20. The Top 10 and 5 Players Market Share by Human Vaccine Adjuvants Revenue in 2020

    Figure 21. Human Vaccine Adjuvants Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020

    Figure 22. Global Human Vaccine Adjuvants Sales Market Share by Type (2016-2021)

    Figure 23. Global Human Vaccine Adjuvants Sales Market Share by Type in 2020

    Figure 24. Global Human Vaccine Adjuvants Revenue Market Share by Type (2016-2021)

    Figure 25. Global Human Vaccine Adjuvants Revenue Market Share by Type in 2020

    Figure 26. Global Human Vaccine Adjuvants Sales Market Share by Application (2016-2021)

    Figure 27. Global Human Vaccine Adjuvants Sales Market Share by Application in 2020

    Figure 28. Global Human Vaccine Adjuvants Revenue Market Share by Application (2016-2021)

    Figure 29. Global Human Vaccine Adjuvants Revenue Market Share by Application in 2020

    Figure 30. USA Human Vaccine Adjuvants Sales Growth Rate 2016-2027 (MT)

    Figure 31. USA Human Vaccine Adjuvants Revenue Growth Rate 2016-2027 (US$ Million)

    Figure 32. USA Human Vaccine Adjuvants Market Share in Global Market 2016-2027

    Figure 33. USA 5 and 10 Largest Human Vaccine Adjuvants Players Market Share by Revenue in Human Vaccine Adjuvants in 2020

    Figure 34. USA Human Vaccine Adjuvants Revenue Share by Type (2016-2021)

    Figure 35. USA Human Vaccine Adjuvants Revenue Growth Rate by Type in 2016 & 2020

    Figure 36. USA Human Vaccine Adjuvants Revenue Share by Application (2016-2021)

    Figure 37. USA Human Vaccine Adjuvants Revenue Growth Rate by Application in 2016 & 2020

    Figure 38. North America Human Vaccine Adjuvants Sales Growth Rate 2016-2021 (MT)

    Figure 39. North America Human Vaccine Adjuvants Revenue Growth Rate 2016-2021 (US$ Million)

    Figure 40. North America Human Vaccine Adjuvants Sales Market Share by Country in 2020

    Figure 41. North America Human Vaccine Adjuvants Revenue Market Share by Country in 2020

    Figure 42. the United States Human Vaccine Adjuvants Sales Growth Rate (2016-2021) (MT)

    Figure 43. the United States Human Vaccine Adjuvants Revenue Growth Rate (2016-2021) (US$ Million)

    Figure 44. Canada Human Vaccine Adjuvants Sales Growth Rate (2016-2021) (MT)

    Figure 45. Canada Human Vaccine Adjuvants Revenue Growth Rate (2016-2021) (US$ Million)

    Figure 46. Europe Human Vaccine Adjuvants Sales Growth Rate 2016-2021 (MT)

    Figure 47. Europe Human Vaccine Adjuvants Revenue Growth Rate 2016-2021 (US$ Million)

    Figure 48. Europe Human Vaccine Adjuvants Sales Market Share by Country in 2020

    Figure 49. Europe Human Vaccine Adjuvants Revenue Market Share by Country in 2020

    Figure 50. Germany Human Vaccine Adjuvants Sales Growth Rate (2016-2021) (MT)

    Figure 51. Germany Human Vaccine Adjuvants Revenue Growth Rate (2016-2021) (US$ Million)

    Figure 52. France Human Vaccine Adjuvants Sales Growth Rate (2016-2021) (MT)

    Figure 53. France Human Vaccine Adjuvants Revenue Growth Rate (2016-2021) (US$ Million)

    Figure 54. UK Human Vaccine Adjuvants Sales Growth Rate (2016-2021) (MT)

    Figure 55. UK Human Vaccine Adjuvants Revenue Growth Rate (2016-2021) (US$ Million)

    Figure 56. Italy Human Vaccine Adjuvants Sales Growth Rate (2016-2021) (MT)

    Figure 57. Italy Human Vaccine Adjuvants Revenue Growth Rate (2016-2021) (US$ Million)

    Figure 58. Russia Human Vaccine Adjuvants Sales Growth Rate (2016-2021) (MT)

    Figure 59. Russia Human Vaccine Adjuvants Revenue Growth Rate (2016-2021) (US$ Million)

    Figure 60. Asia Pacific Human Vaccine Adjuvants Sales Growth Rate 2016-2021 (MT)

    Figure 61. Asia Pacific Human Vaccine Adjuvants Revenue Growth Rate 2016-2021 (US$ Million)

    Figure 62. Asia Pacific Human Vaccine Adjuvants Sales Market Share by Region in 2020

    Figure 63. Asia Pacific Human Vaccine Adjuvants Revenue Market Share by Region in 2020

    Figure 64. China Human Vaccine Adjuvants Sales Growth Rate (2016-2021) (MT)

    Figure 65. China Human Vaccine Adjuvants Revenue Growth Rate (2016-2021) (US$ Million)

    Figure 66. Japan Human Vaccine Adjuvants Sales Growth Rate (2016-2021) (MT)

    Figure 67. Japan Human Vaccine Adjuvants Revenue Growth Rate (2016-2021) (US$ Million)

    Figure 68. South Korea Human Vaccine Adjuvants Sales Growth Rate (2016-2021) (MT)

    Figure 69. South Korea Human Vaccine Adjuvants Revenue Growth Rate (2016-2021) (US$ Million)

    Figure 70. India Human Vaccine Adjuvants Sales Growth Rate (2016-2021) (MT)

    Figure 71. India Human Vaccine Adjuvants Revenue Growth Rate (2016-2021) (US$ Million)

    Figure 72. Australia Human Vaccine Adjuvants Sales Growth Rate (2016-2021) (MT)

    Figure 73. Australia Human Vaccine Adjuvants Revenue Growth Rate (2016-2021) (US$ Million)

    Figure 74. China Taiwan Human Vaccine Adjuvants Sales Growth Rate (2016-2021) (MT)

    Figure 75. China Taiwan Human Vaccine Adjuvants Revenue Growth Rate (2016-2021) (US$ Million)

    Figure 76. Indonesia Human Vaccine Adjuvants Sales Growth Rate (2016-2021) (MT)

    Figure 77. Indonesia Human Vaccine Adjuvants Revenue Growth Rate (2016-2021) (US$ Million)

    Figure 78. Thailand Human Vaccine Adjuvants Sales Growth Rate (2016-2021) (MT)

    Figure 79. Thailand Human Vaccine Adjuvants Revenue Growth Rate (2016-2021) (US$ Million)

    Figure 80. Malaysia Human Vaccine Adjuvants Sales Growth Rate (2016-2021) (MT)

    Figure 81. Malaysia Human Vaccine Adjuvants Revenue Growth Rate (2016-2021) (US$ Million)

    Figure 82. Latin America Human Vaccine Adjuvants Sales Growth Rate 2016-2021 (MT)

    Figure 83. Latin America Human Vaccine Adjuvants Revenue Growth Rate 2016-2021 (US$ Million)

    Figure 84. Latin America Human Vaccine Adjuvants Sales Market Share by Country in 2020

    Figure 85. Latin America Human Vaccine Adjuvants Revenue Market Share by Country in 2020

    Figure 86. Mexico Human Vaccine Adjuvants Sales Growth Rate (2016-2021) (MT)

    Figure 87. Mexico Human Vaccine Adjuvants Revenue Growth Rate (2016-2021) (US$ Million)

    Figure 88. Brazil Human Vaccine Adjuvants Sales Growth Rate (2016-2021) (MT)

    Figure 89. Brazil Human Vaccine Adjuvants Revenue Growth Rate (2016-2021) (US$ Million)

    Figure 90. Argentina Human Vaccine Adjuvants Sales Growth Rate (2016-2021) (MT)

    Figure 91. Argentina Human Vaccine Adjuvants Revenue Growth Rate (2016-2021) (US$ Million)

    Figure 92. Middle East and Africa Human Vaccine Adjuvants Sales Growth Rate 2016-2021 (MT)

    Figure 93. Middle East and Africa Human Vaccine Adjuvants Revenue Growth Rate 2016-2021 (US$ Million)

    Figure 94. Middle East and Africa Human Vaccine Adjuvants Sales Market Share by Country in 2020

    Figure 95. Middle East and Africa Human Vaccine Adjuvants Revenue Market Share by Country in 2020

    Figure 96. Turkey Human Vaccine Adjuvants Sales Growth Rate (2016-2021) (MT)

    Figure 97. Turkey Human Vaccine Adjuvants Revenue Growth Rate (2016-2021) (US$ Million)

    Figure 98. Saudi Arabia Human Vaccine Adjuvants Sales Growth Rate (2016-2021) (MT)

    Figure 99. Saudi Arabia Human Vaccine Adjuvants Revenue Growth Rate (2016-2021) (US$ Million)

    Figure 100. UAE Human Vaccine Adjuvants Sales Growth Rate (2016-2021) (MT)

    Figure 101. UAE Human Vaccine Adjuvants Revenue Growth Rate (2016-2021) (US$ Million)

    Figure 102. Human Vaccine Adjuvants Value Chain

    Figure 103. Channels of Distribution

    Figure 104. Distributors Profiles

    Figure 105. Bottom-up and Top-down Approaches for This Report

    Figure 106. Data Triangulation

    Figure 107. Key Executives Interviewed